The Journal of Urology
Volume 181, Issue 3 , Pages 980-984 , March 2009

Epigenetic Reprogramming: A Possible Etiological Factor in Bladder Pain Syndrome/Interstitial Cystitis?

  • Ada Elgavish

      Affiliations

    • Financial interest and/or other relationship with Diacell, Inc. and Elgavish Paramagnetics.
    • Corresponding Author InformationCorrespondence: Department of Genetics, Kaul Building, 720 20th St. S, Room 652, University of Alabama at Birmingham, Birmingham, Alabama 35294-0024

Received 16 July 2008

References 

  1. Parsons J, Parsons CL. The historical origins of interstitial cystitis. J Urol. 2004;171:20
  2. Wein AJ, Hanno P, Gillenwater J. Interstitial cystitis: an introduction to the problem. In:  Hanno P,  Staskin DR,  Krane RJ,  Wein AJ editor. Interstitial Cystitis. London: Springer Verlag; 1990;
  3. Hanno P, Nordling J, van Ophoven A. What is new in bladder pain syndrome/interstitial cystitis?. Curr Opin Urol. 2008;18:353
  4. van de Merwe J, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60
  5. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology. 1997;49(suppl.):14
  6. Warren JW. Interstitial cystitis as an infectious disease. Urol Clin North Am. 1994;21:31
  7. Anderson J, Parivar F, Lee G, Wallington TB, MacIver AG, Bradbrook RA, et al. The enigma of IC—an autoimmune disease?. Br J Urol. 1989;63:58
  8. Parsons C. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology. 2007;69(suppl.):9
  9. Teichman J, Moldwin R. The role of bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol. 2007;14:3599
  10. Sant G, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007;69(suppl.):34
  11. Nazif O, Teichman JMH, Gebhart GF. Neural upregulation in interstitial cystitis. Urology. 2007;69(suppl.):24
  12. Saban MR, Nguyen NB, Hammond TG, Saban R. Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P and antigen stimulation. Am J Pathol. 2002;160:2095
  13. Elgavish A, Lloyd K, Reed R. A subpopulation of human urothelial cells is stimulated to proliferate by treatment in vitro with lipoteichoic acid, a cell wall component of Streptococcus faecalis. J Cell Physiol. 1996;169:42
  14. Elgavish A, Pattanaik A, Couchman J, Woods A, Lloyd K, Lindsey JR, et al. Long-term treatment with lipoteichoic acid from Streptococcus faecalis affects differentiation, and expression and cellular distribution of beta 1 integrins in human urothelial cells. J Cell Physiol. 1996;169:52
  15. Elgavish A, Robert B, Lloyd K, Reed R. Nitric oxide mediates the action of lipoteichoic acid on the function of human urothelial cells. J Cell Physiol. 1996;169:66
  16. Elgavish A. NF-kB activation mediates the response of a subpopulation of basal uroepithelial cells to a cell wall component of Enterococcus faecalis. J Cell Physiol. 2000;182:232
  17. Apodaca G, Balestreire E, Birder LA. The uroepithelial-associated sensory web. Kidney Int. 2007;72:1057
  18. Everaerts W, Gevaert T, Nilius B, De Ridder D. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn. 2008;27:264
  19. Brading A, McCloskey KD. Mechanisms of disease: specialized interstitial cells of the urothelium: an assessment of current knowledge. Nat Clin Pract Urol. 2005;2:546
  20. Birder L. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol. 2005;289:F489
  21. Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG, Saban R. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics. 2001;5:147
  22. Okragly A, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol. 1999;161:438
  23. Aronson M, Medalia O, Amichay D, Nativ O. Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism. Infect Immun. 1988;56:1615
  24. Mulvey M, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science. 1998;282:1494
  25. Elliott TS, Reed L, Slack RC, Bishop MC. Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect. 1985;11:191
  26. Morrison S, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell. 1997;88:287
  27. Elgavish A. A hypothesis for the etiology of interstitial cystitis. In:  Atala A,  Slade D editor. Bladder Diseases: Research Concepts and Clinical Applications. New York: Kluwer Academic/Plenum Publishers; 2003;p. 683–712chapt 43
  28. Ito T, Ueda T, Homma Y, Takei M. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int J Urol. 2007;14:1068
  29. Elgavish A, Pattanaik A, Lloyd K, Reed R. Evidence for altered proliferative ability of progenitors of of urothelial cells in interstitial cystitis. J Urol. 1997;158:248
  30. Molofsky A, Pardal R, Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol. 2004;16:700
  31. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(suppl.):245
  32. Saldanha SN, Nandakumar V, Elgavish A, Tollefsbol TO. Dietary and environmental influences on histone modifications in cancer. In:  Tollefsbol T editors. Cancer Epigenetics. New York: CRC Press; 2008;
  33. Orlando V. Polycomb, epigenomes, and control of cell identity. Cell. 2003;112:599
  34. Jepsen K, Solum D, Zhou T, McEvilly RJ, Kim HJ, Glass CK, et al. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature. 2007;450:415
  35. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell. 2007;130:1083
  36. Bracken A, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123
  37. Surani M, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell. 2007;128:747
  38. Jones R. Reversing the ‘irreversible'. Nature. 2007;450:357
  39. Swigut T, Wycocka J. H3K27 demethylases, at long last. Cell. 2007;131:29
  40. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313
  41. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318
  42. The AACR Human Epigenome Task Force and European Union, Network of Excellence, Scientific Advisory Board. Moving AHEAD with an international human epigenome project. Nature. 2008;454:711
  43. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457

PII: S0022-5347(08)02993-5

doi: 10.1016/j.juro.2008.10.145

The Journal of Urology
Volume 181, Issue 3 , Pages 980-984 , March 2009

Article Tools